Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-20T07:24:08.000Z Has data issue: false hasContentIssue false

2120 – Feasibility Of The Use Of The Screen For Cognitive Impairment In Psychiatry (scip) In a Clinical Population With Adult Attention Deficit Disorder

Published online by Cambridge University Press:  15 April 2020

S.V. Tourjman
Affiliation:
Department of Psychiatry, Hôpital Louis H.Lafontaine, Centre de Recherche Fernand Seguin, Université de Montréal, QC, Canada
A. Djouini
Affiliation:
Centre de Recherche Fernand Seguin, Montréal, QC, Canada
P. Baruch
Affiliation:
Psychiatrie, Université Laval, Québec, QC, Canada
S. Beaulieu
Affiliation:
Psychiatry, McGill University, QC, Canada
R. Bergeron
Affiliation:
University of Ottawa, QC, Canada
F. Chanut
Affiliation:
Département de Psychiatrie du Centre Hospitalier de l’Université de Montréal, University of Montréal, QC, Canada
A. Daigneault
Affiliation:
McGill University, Montréal, QC, Canada
L. Li
Affiliation:
Institute of Mental Health, Peking University, Beijing, China
S. Purdon
Affiliation:
University of Alberta, Edmonton, AB
S. Renaud
Affiliation:
McGill University, Montréal, QC, Canada
É.C. Villeneuve
Affiliation:
Département de Psychiatrie, Université Laval, Québec, QC, Canada

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Cognitive impairment is central to many psychiatric conditions and is a determinant factor of functioning. The evaluation of cognition is time-consuming and recourse to it limited by cost, accessibility of expertise, and, in the case of computerized batteries, equipment. The SCIP is a 15 minute paper and pencil evaluation of cognitive function which can be integrated into clinical practice. It is thus a tool which can assist in determining which patients require a more extensive evaluation and can inform the elaboration of a personalized treatment plan. Our group (Groupe Comorbidité psychiatrique et Dimensions) has validated a french translation of the SCIP and is testing the acceptability of its integration into clinical practice in selected clinical populations. We will present preliminary data regarding the use of the SCIP in adult attention deficit disorder. Forty adult patients with attention deficit disorder were invited to participate in the study. In order to maintain a sample representative of clinical practice the only exclusion criteria were inability to speak french and inability to give informed consent. Demographic characteristics were collected, and a multiaxial DSM-IV diagnosis determined by the treating physician, SCIP was administered. The time to administer the SCIP was recorded, and a qualitative questionnaire of patient impressions was completed. We will present preliminary results of this study.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.